WeVote

Bill

Bill

AB 1778

Controlled substances: testosterone.

2025-2026 Regular Session Introduced by Joe Patterson

California bill proposes classifying testosterone as controlled substance, potentially restricting medical access while targeting performance-enhancing abuse.

In Assembly. Concurrence in Senate amendments pending.
0
WeVote Research Nonpartisan
Bill Summary · AB 1778

Legislative bill overview

AB 1778 proposes to regulate testosterone as a controlled substance in California. The bill was recently introduced and referred to the Business & Professions and Public Safety committees for review. It remains in early legislative stages with committee hearings potentially beginning in March 2026.

Why is this important

Testosterone classification affects medical practice, athletics, and individuals using hormone therapies. Such regulation would impact doctors prescribing testosterone for legitimate medical conditions (hormone replacement therapy, hypogonadism), athletes subject to sports regulations, and transgender individuals accessing gender-affirming care. The outcome could significantly reshape California's approach to hormone regulation and healthcare delivery.

Potential points of contention

  • Medical access vs. abuse prevention: Balancing legitimate therapeutic uses against potential misuse in bodybuilding and performance enhancement
  • Transgender healthcare implications: Concerns that controlled substance classification could restrict access to gender-affirming care or create medical/legal barriers
  • Federalism and consistency: California's classification may conflict with federal DEA scheduling or complicate interstate medical practice and pharmaceutical distribution

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.